Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Akorn, Inc.    AKRX

AKORN, INC. (AKRX)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

AKRX LOSS NOTICE: Rosen Law Firm Reminds Akorn, Inc. Investors of Important Deadline in Class Action

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/14/2018 | 02:46am CEST

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akorn, Inc. (NASDAQ:AKRX) from March 1, 2017 through February 26, 2018, both dates inclusive (“Class Period”) of the important May 7, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Akorn investors under the federal securities laws.

To join the Akorn class action, go to http://www.rosenlegal.com/cases-1301.html or call Phillip Kim, Esq. or Zachary Halper, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Akorn’s failure to comply with FDA data integrity requirements would jeopardize Fresenius’s acquisition of Akorn; (2) Akorn lacked effective internal controls over financial reporting; and (3) as a result, Akorn’s financial statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 7, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1301.html to join the class action. You may also contact Phillip Kim or Zachary Halper of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.


© Business Wire 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AKORN, INC.
05/29MOORE KUEHN, PLLC : Announces an Investigation Involving Possible Breaches of Fi..
PR
05/18AKORN : Fresenius CEO defends cancelled Akorn deal
RE
05/11AKORN, INC. : Free Daily Technical Summary Reports on Horizon Pharma and Three M..
AC
05/07AKORN, INC. : DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders of Akor..
AC
05/07AKORN, INC. : DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Secu..
AC
05/07AKORN, INC. : FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies..
AC
05/04AKORN, INC. : DEADLINE MONDAY: The Klein Law Firm Reminds Investors of a Class A..
AC
05/04AKORN, INC. : Pawar Law: Important May 7, 2018 Lead Plaintiff Deadline in Akorn,..
AC
05/04AKORN, INC. : DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Inves..
AC
05/03AKORN, INC. : MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Sec..
AC
More news
News from SeekingAlpha
06/19Merger Arbitrage Mondays - June 18, 2018 
06/13With Mylan's Neulasta Biosimilar Approval, Focus Moves To Advair And Restasis 
06/08AKORN AND FRESENIUS : Merger Arbitrage 
05/31FDA issues draft guidance aimed at easing regulatory path for generic drugs 
05/13SA INTERVIEW : Event-Driven Investing With Donostia 
Financials ($)
Sales 2018 740 M
EBIT 2018 78,8 M
Net income 2018 -2,00 M
Debt 2018 522 M
Yield 2018 -
P/E ratio 2018 168,92
P/E ratio 2019 49,76
EV / Sales 2018 3,35x
EV / Sales 2019 3,30x
Capitalization 1 957 M
Chart AKORN, INC.
Duration : Period :
Akorn, Inc. Technical Analysis Chart | AKRX | US0097281069 | 4-Traders
Technical analysis trends AKORN, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Average target price 26,8 $
Spread / Average Target 70%
EPS Revisions
Managers
NameTitle
Rajat Rai Chief Executive Officer
Alan D. Weinstein Chairman
Bruce Kutinsky Chief Operating Officer
Duane A. Portwood CFO & Executive Vice President
Mark M. Silverberg Executive VP-Operations & Technical Services
Sector and Competitors
1st jan.Capitalization (M$)
AKORN, INC.-50.67%1 957
JOHNSON & JOHNSON-12.27%327 330
PFIZER0.00%213 275
NOVARTIS-10.87%189 575
ROCHE HOLDING LTD.-12.58%188 417
MERCK AND COMPANY8.90%164 862